drugset / Trial / NCT00026637
Depression and Health Outcomes in Refractory Epilepsy
Phase 3
Completed
140 enrolled
Columbia University
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in persons with depression and refractory epilepsy.
Timeline
- Start
- 2001-08
- Primary completion
- 2007-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sertraline | Small molecule | — | Oral |